BCL2 and mantle cell lymphoma: In a model of MCL, resistance to venetoclax was observed to evolve from outgrowth of “persister” clones displaying a loss of 18q21 amplicons harboring BCL2 as well as adaptive super enhancer-driven transcriptional reprogramming [112].